Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Indivior PLC - Ordinary Shares (NQ: INDV )

9.680 +0.090 (+0.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Indivior PLC - Ordinary Shares

< Previous 1 2 Next >
European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat
Indivior's 2025 outlook missed estimates, citing Suboxone sales erosion. The company plans $100 million in cost cuts, with $50M reinvested in Sublocade. 
Via Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
Earnings Scheduled For February 20, 2025
Via Benzinga
Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
S&P Moves Lower; Domino's Pizza Posts Mixed Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Crude Oil Surges 3%; Delta Air Lines Posts Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details
Indivior cuts FY24 net revenue outlook due to competition and funding delays, causing a drop in share price. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Top 3 Health Care Stocks That May Explode This Month
Via Benzinga
Smith & Wesson Brands Reports Downbeat Results, Joins Planet Labs PBC, Broadcom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
French Biotech Candidate For Cannabis Use Disorder Fails Phase 2B Clinical Trial, Indivior Will Not Exercise Option
Via Benzinga
Topics Cannabis
Exposures Cannabis
Health And Human Services Dept Orders OPVEE Nasal Spray For Emergency Fentanyl Overdose Response
Via Benzinga
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
Addex Therapeutics stock surged after announcing clinical candidate selection with Indivior for substance use disorder treatment. Addex could receive up to $330 million plus royalties under the... 
Via Benzinga
DexCom, Zynex, Olin And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
INDV Stock Earnings: Indivior Beats EPS, Beats Revenue for Q2 2024
INDV stock results show that Indivior beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Wells Fargo Posts Q2 Earnings, Joins Snowflake And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
S&P 500 Edges Higher; Indivior Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Down 1%; Soligenix Shares Surge
Via Benzinga
Exposures Fossil Fuels
What's Going On With Addiction And Mental Illnesses-Focused Indivior Stock On Tuesday?
Indivior lowers its profit forecast for 2024, discontinues sales of its schizophrenia drug Perseris, and announces job cuts, causing shares to plummet nearly 38%. The company updates its financial... 
Via Benzinga
Why Is Soligenix (SNGX) Stock Up 296% Today?
Soligenix stock is up on Tuesday with heavy trading of SNGX shares alongside positive clinical trial data from the company. 
Via InvestorPlace
Dow Falls Over 50 Points; US Small Business Optimism Surges In June
Via Benzinga
Topics Stocks
Exposures US Equities
Why Is Helen Of Troy (HELE) Stock Down 25% Today?
Helen Of Troy stock is taking a beating on Tuesday as HELE investors react to lackluster earnings and lowered outlooks in its Q1 report. 
Via InvestorPlace
Why Is Indivior (INDV) Stock Down 37% Today?
Indivior stock is down on Tuesday as INDV investors react to a business update that includes lowered outlooks for Q2 and 2024. 
Via InvestorPlace
Indivior Cuts 2024 Outlook, Joins BP And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.